当前位置：
X-MOL 学术
›
J. Neurol. Sci.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Myasthenic crisis in COVID-19
Journal of the Neurological Sciences ( IF 4.4 ) Pub Date : 2020-07-01 , DOI: 10.1016/j.jns.2020.116888 Fadi Delly 1 , Maryam J Syed 2 , Robert P Lisak 3 , Deepti Zutshi 2
Journal of the Neurological Sciences ( IF 4.4 ) Pub Date : 2020-07-01 , DOI: 10.1016/j.jns.2020.116888 Fadi Delly 1 , Maryam J Syed 2 , Robert P Lisak 3 , Deepti Zutshi 2
Affiliation
Highlights • Myasthenic crises is a potentially severe complication of COVID-19.• Hydroxychloroquine can aggravate myasthenia crises.• IVIg is a potential treatment for both Myasthenic crises and COVID-19.• IVIg treatment may cause thrombosis in susceptible patients.
中文翻译：
COVID-19 中的肌无力危机
亮点 • 肌无力危象是 COVID-19 的潜在严重并发症。• 羟氯喹可加重肌无力危象。• IVIg 是肌无力危象和 COVID-19 的潜在治疗方法。• IVIg 治疗可能导致易感患者血栓形成。
更新日期：2020-07-01
中文翻译：
COVID-19 中的肌无力危机
亮点 • 肌无力危象是 COVID-19 的潜在严重并发症。• 羟氯喹可加重肌无力危象。• IVIg 是肌无力危象和 COVID-19 的潜在治疗方法。• IVIg 治疗可能导致易感患者血栓形成。
京公网安备 11010802027423号